{"id":"duloxetine-cymbalta","safety":{"commonSideEffects":[{"rate":"20-25","effect":"Nausea"},{"rate":"10-15","effect":"Dizziness"},{"rate":"10-12","effect":"Somnolence"},{"rate":"10-15","effect":"Dry mouth"},{"rate":"8-10","effect":"Fatigue"},{"rate":"8-10","effect":"Constipation"},{"rate":"5-8","effect":"Decreased appetite"},{"rate":"12-14","effect":"Headache"},{"rate":"5-10","effect":"Sexual dysfunction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a serotonin-norepinephrine reuptake inhibitor (SNRI), duloxetine blocks the reuptake transporters for both serotonin and norepinephrine, prolonging their action in the synapse. This dual mechanism is thought to enhance mood regulation and pain signaling modulation, making it effective for both psychiatric and pain-related conditions.","oneSentence":"Duloxetine inhibits the reuptake of serotonin and norepinephrine in the central nervous system, increasing their availability at synaptic sites.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:35:44.978Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"},{"name":"Diabetic peripheral neuropathic pain"},{"name":"Fibromyalgia"},{"name":"Chronic musculoskeletal pain"},{"name":"Stress urinary incontinence"}]},"trialDetails":[{"nctId":"NCT07498140","phase":"NA","title":"Procedural Framing and Epidural Steroid Injection Outcomes","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2026-03-25","conditions":"Lumbosacral Radiculopathy","enrollment":210},{"nctId":"NCT07495943","phase":"NA","title":"Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2026-05-04","conditions":"Fibromyalgia Syndrome, Fibromyalgia","enrollment":200},{"nctId":"NCT06807866","phase":"PHASE4","title":"Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-01","conditions":"THA","enrollment":64},{"nctId":"NCT05851898","phase":"PHASE4","title":"Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-04-08","conditions":"Depression in Old Age, Fragility Fracture","enrollment":100},{"nctId":"NCT07455838","phase":"NA","title":"Impact of Virtual Reality Pelvic Floor Training on Postpartum Stress Urinary Incontinence","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-10","conditions":"Stress Urinary Incontinence","enrollment":50},{"nctId":"NCT07326163","phase":"NA","title":"The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Bilecik Seyh Edebali Universitesi","startDate":"2026-03-01","conditions":"Fibromyalgia, Aromatherapy, Cost","enrollment":175},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":"Liver Cirrhosis With Diabetes","enrollment":64},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT07431606","phase":"PHASE2","title":"Duloxetine in Inflammatory Bowel Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-03-01","conditions":"Inflammatory Bowel Diseases","enrollment":32},{"nctId":"NCT07400471","phase":"EARLY_PHASE1","title":"The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy.","status":"RECRUITING","sponsor":"Chattogram International Dental College","startDate":"2026-02-06","conditions":"Post Endodontic Pain, Mechanical Detection Threshold, Mechanical Pain Threshold","enrollment":280},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT06997198","phase":"PHASE4","title":"Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities","status":"NOT_YET_RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2026-03-01","conditions":"Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities","enrollment":25},{"nctId":"NCT05814640","phase":"PHASE1, PHASE2","title":"Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-02-20","conditions":"Depression, Sequestra","enrollment":520},{"nctId":"NCT04137107","phase":"PHASE2, PHASE3","title":"Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2020-06-17","conditions":"Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8","enrollment":220},{"nctId":"NCT04747314","phase":"PHASE2, PHASE3","title":"Treating Negative Affect in Low Back Pain Patients","status":"COMPLETED","sponsor":"Ajay Wasan, MD, Msc","startDate":"2021-03-31","conditions":"Chronic Low Back Pain, Negative Affectivity","enrollment":308},{"nctId":"NCT05110144","phase":"PHASE2","title":"Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-01","conditions":"Refractory Chronic Cough","enrollment":50},{"nctId":"NCT05120934","phase":"PHASE2","title":"Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-01","conditions":"Interstitial Lung Disease","enrollment":25},{"nctId":"NCT04862845","phase":"PHASE1","title":"Combination of Duloxetine and Pregabalin to Improve Postoperative Pain","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-07-30","conditions":"Postoperative Pain","enrollment":90},{"nctId":"NCT07348952","phase":"NA","title":"Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-09-01","conditions":"Transcutaneous Electrical Nerve Stimulation, Pudendal Neuralgia, Post Prostatectomy","enrollment":60},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT06837857","phase":"PHASE2","title":"Prescription Opioids, Brain Structure, and Cognition in Older Adults With Chronic Pain","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-16","conditions":"Pain, Chronic","enrollment":200},{"nctId":"NCT07203339","phase":"NA","title":"Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2025-09-30","conditions":"Fibromyalgia (FM), tDCS, Duloxetine","enrollment":610},{"nctId":"NCT06672419","phase":"NA","title":"Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)","status":"NOT_YET_RECRUITING","sponsor":"Instituto Neurociencia Del Dolor","startDate":"2026-02-01","conditions":"Fibromyalgia, Fibromyalgia Syndrome","enrollment":50},{"nctId":"NCT06965569","phase":"PHASE1","title":"Multiple Ascending Dose Phase 1 Study of ALA-3000","status":"COMPLETED","sponsor":"Alar Pharmaceuticals Inc.","startDate":"2025-04-21","conditions":"Treatment Resistant Depression","enrollment":37},{"nctId":"NCT04560673","phase":"PHASE2","title":"Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-10","conditions":"Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":380},{"nctId":"NCT07296770","phase":"PHASE3","title":"An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-05-01","conditions":"Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After Surgery","enrollment":126},{"nctId":"NCT06423716","phase":"PHASE4","title":"Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-11-01","conditions":"Knee Osteoarthritis","enrollment":150},{"nctId":"NCT06715462","phase":"PHASE3","title":"Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Painful Diabetic Peripheral Neuropathy (PDPN)","enrollment":""},{"nctId":"NCT06614322","phase":"PHASE2","title":"SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-01","conditions":"Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":190},{"nctId":"NCT04870957","phase":"PHASE4","title":"The Back Pain Consortium Research Program Study","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-06-09","conditions":"Chronic Low-back Pain","enrollment":494},{"nctId":"NCT05311774","phase":"NA","title":"Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-04-01","conditions":"Cancer Pain","enrollment":400},{"nctId":"NCT05851976","phase":"PHASE4","title":"Duloxetine for LBP","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2023-10-04","conditions":"Back Pain, Low","enrollment":120},{"nctId":"NCT06842992","phase":"PHASE2","title":"A Phase II Study to Evaluate NH102 for Depression","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2024-12-04","conditions":"Major Depressive Disorder (MDD)","enrollment":243},{"nctId":"NCT07253207","phase":"PHASE3","title":"Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder","status":"COMPLETED","sponsor":"Zhejiang Huahai Pharmaceutical Co., Ltd.","startDate":"2024-10-17","conditions":"Major Depressive Disorder (MDD)","enrollment":392},{"nctId":"NCT06259526","phase":"PHASE2","title":"A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-12-26","conditions":"Depression","enrollment":267},{"nctId":"NCT06860984","phase":"PHASE3","title":"Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-03-10","conditions":"Biliary Disease","enrollment":44},{"nctId":"NCT05086393","phase":"PHASE4","title":"Duloxetine RCT on Postop TKA Outcomes","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2021-11-01","conditions":"Pain, Postoperative, Total Knee Arthroplasty","enrollment":241},{"nctId":"NCT03548454","phase":"PHASE4","title":"Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-09-20","conditions":"Chronic Pain","enrollment":86},{"nctId":"NCT04395001","phase":"PHASE4","title":"Pain Response Evaluation of a Combined Intervention to Cope Effectively","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-02-24","conditions":"Chronic Pain","enrollment":280},{"nctId":"NCT04111627","phase":"PHASE2","title":"Exercise Plus Duloxetine for Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2021-10-07","conditions":"Knee Osteoarthritis, Depression","enrollment":43},{"nctId":"NCT07161492","phase":"NA","title":"A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2025-09","conditions":"Depressive Disorder, Major, Cognitive Impairment","enrollment":182},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT06866444","phase":"","title":"Duloxetine Metabolism and Fibromyalgia","status":"RECRUITING","sponsor":"University of Utah","startDate":"2025-05-01","conditions":"Fibromyalgia, Duloxetine","enrollment":100},{"nctId":"NCT07120880","phase":"PHASE3","title":"Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Major Depressive Disorder (MDD) With Insomnia","enrollment":184},{"nctId":"NCT06087211","phase":"NA","title":"Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2023-10-10","conditions":"Duloxetine, Magnesium Sulphate, Post-mastectomy Pain Syndrome","enrollment":90},{"nctId":"NCT05976347","phase":"PHASE4","title":"Identifying and Treating Depression in the Orthopaedic Trauma Population","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-06-25","conditions":"Depression","enrollment":100},{"nctId":"NCT05396014","phase":"PHASE4","title":"The BEST Trial: Biomarkers for Evaluating Spine Treatments","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-09-12","conditions":"Chronic Low-back Pain","enrollment":1014},{"nctId":"NCT06245109","phase":"PHASE4","title":"Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-02-26","conditions":"Knee Osteoarthritis","enrollment":180},{"nctId":"NCT03794362","phase":"","title":"Measuring Analgesic Interventions","status":"RECRUITING","sponsor":"Julia Finkel","startDate":"2018-10-29","conditions":"Pain","enrollment":120},{"nctId":"NCT07025590","phase":"NA","title":"Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2025-04-22","conditions":"Cardiovascular Diseases (CVD), Depression Anxiety Disorder","enrollment":106},{"nctId":"NCT06968624","phase":"PHASE4","title":"Ketamine for Postherpetic Neuralgia With Depression","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-06-15","conditions":"Depression Disorders, Herpetic Neuralgia","enrollment":50},{"nctId":"NCT05611749","phase":"PHASE2","title":"Duloxetine Impact on Postoperative Pain Control and Outcomes","status":"TERMINATED","sponsor":"Scripps Health","startDate":"2023-05-30","conditions":"Acute Post-operative Pain, Chronic Post Operative Pain, Narcotic Use","enrollment":17},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT03434041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-25","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":252},{"nctId":"NCT02493868","phase":"PHASE3","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":719},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02497287","phase":"PHASE3","title":"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09-30","conditions":"Treatment-resistant Depression","enrollment":802},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT03321526","phase":"PHASE2","title":"A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-12-12","conditions":"Depressive Disorder, Major","enrollment":107},{"nctId":"NCT06896994","phase":"NA","title":"Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic Neuralgia","enrollment":150},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT04504812","phase":"PHASE3","title":"A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-02-01","conditions":"Knee Osteoarthritis","enrollment":1937},{"nctId":"NCT03575403","phase":"PHASE1","title":"Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)","status":"COMPLETED","sponsor":"Craig Rush","startDate":"2018-09-01","conditions":"Alcohol Use Disorder","enrollment":19},{"nctId":"NCT06914557","phase":"PHASE2","title":"Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2025-03-03","conditions":"CIPN - Chemotherapy-Induced Peripheral Neuropathy, Pain","enrollment":50},{"nctId":"NCT05558397","phase":"NA","title":"Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment","status":"COMPLETED","sponsor":"Universidade Federal de Alfenas","startDate":"2018-04-01","conditions":"Cancer Pain, Opioid Use, Cost Analysis","enrollment":32},{"nctId":"NCT05786599","phase":"PHASE2, PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":50},{"nctId":"NCT06837012","phase":"PHASE4","title":"Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Orthopaedic Arthroscopy Knee and Shoulder Clinic","startDate":"2021-01-01","conditions":"Osteoarthritis of Knee, Central Sensitization, Central Sensitisation","enrollment":106},{"nctId":"NCT06429605","phase":"NA","title":"Evaluating the Efficacy and Safety of Preoperative Administration of Duloxetine for Pain Management in Women Undergoing Hysterectomy Via Vaginal Route","status":"COMPLETED","sponsor":"Erzincan Military Hospital","startDate":"2024-05-20","conditions":"Vaginal Hysterectomy, Postoperative Pain, vNOTES","enrollment":80},{"nctId":"NCT00071708","phase":"","title":"Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial","status":"APPROVED_FOR_MARKETING","sponsor":"Eli Lilly and Company","startDate":"","conditions":"Major Depressive Disorder, Fibromyalgia, Diabetic Peripheral Neuropathic Pain","enrollment":""},{"nctId":"NCT03271151","phase":"PHASE4","title":"Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-09-28","conditions":"Joint Disease, Pain, Acute, Pain, Chronic","enrollment":160},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT05267873","phase":"","title":"Combining Data Sources to Identify Effect Moderation for Personalized Mental Health","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2015-01-01","conditions":"Depressive Disorder, Major","enrollment":9586},{"nctId":"NCT04446039","phase":"","title":"Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-07-04","conditions":"Major Depression","enrollment":370212},{"nctId":"NCT06711978","phase":"NA","title":"Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Pusan National University Yangsan Hospital","startDate":"2024-12-01","conditions":"CIPN, CIPN - Chemotherapy-Induced Peripheral Neuropathy, CIPN in Adjuvant Breast Cancer Patients","enrollment":66},{"nctId":"NCT05510856","phase":"PHASE4","title":"Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-09-01","conditions":"Oncology","enrollment":93},{"nctId":"NCT05508516","phase":"EARLY_PHASE1","title":"Shugan Dingtong Decoction in the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"China-Japan Friendship Hospital","startDate":"2022-09-01","conditions":"Fibromyalgia","enrollment":72},{"nctId":"NCT03249558","phase":"PHASE4","title":"Effect of Combined Morphine and Duloxetine on Chronic Pain","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-03-12","conditions":"Chronic Low Back Pain, Chronic Neck Pain","enrollment":81},{"nctId":"NCT05065671","phase":"PHASE1","title":"Microbiome Derived Metabolism and Pharmacokinetics","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-02-01","conditions":"Microbial Colonization","enrollment":14},{"nctId":"NCT06407401","phase":"PHASE3","title":"Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2024-12","conditions":"ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I","enrollment":399},{"nctId":"NCT06107829","phase":"PHASE4","title":"Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities","status":"WITHDRAWN","sponsor":"Stephen Ruedrich","startDate":"2025-01","conditions":"Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities","enrollment":""},{"nctId":"NCT03797560","phase":"NA","title":"Comparison of Ba-Duan-Jin and Pregabalin in Patients with Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-22","conditions":"Fibromyalgia","enrollment":104},{"nctId":"NCT03890133","phase":"NA","title":"Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-04-01","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT04970121","phase":"PHASE2","title":"Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy","status":"RECRUITING","sponsor":"Yan Yang, MD, Ph.D","startDate":"2021-08-21","conditions":"Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor","enrollment":100},{"nctId":"NCT06606067","phase":"PHASE3","title":"Duloxetine to Prevent Chronic Postsurgical Pain After Inguinal Hernia Repair in Patients at High Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2024-09-03","conditions":"Chronic Post-surgical Pain","enrollment":294},{"nctId":"NCT06551051","phase":"PHASE2","title":"ADC-induced Neurotoxicity Treated With Duloxetine","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-08-06","conditions":"Solid Tumour","enrollment":37},{"nctId":"NCT04245436","phase":"PHASE4","title":"Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2020-01-01","conditions":"Anxiety, Depressive Symptoms","enrollment":60},{"nctId":"NCT04245748","phase":"PHASE4","title":"Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2020-03-01","conditions":"Anxious Depression, Depression","enrollment":84},{"nctId":"NCT00200902","phase":"PHASE4","title":"Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2005-08","conditions":"Depression","enrollment":88},{"nctId":"NCT05840562","phase":"PHASE3","title":"Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2023-10-20","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":274},{"nctId":"NCT03325959","phase":"NA","title":"Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2017-03-01","conditions":"Fibromyalgia, Hyperbaric Oxygen","enrollment":76},{"nctId":"NCT04316702","phase":"NA","title":"Hyperbaric Oxygen Therapy Compared to Pharmaceutical in Fibromyalgia With Emotional Trauma","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2020-03-01","conditions":"Fibromyalgia, Emotional Trauma","enrollment":48},{"nctId":"NCT06091553","phase":"PHASE2","title":"Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2023-10-10","conditions":"Neuropathy in Cacer Patien","enrollment":160},{"nctId":"NCT05256342","phase":"NA","title":"Biomarkers for Prediction of Analgesic Efficacy in Knee OA.","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2021-12-30","conditions":"Knee, Osteoarthritis (OA), Biomarkers for Prediction of OA Treatment Efficacy","enrollment":17},{"nctId":"NCT04478526","phase":"NA","title":"Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions","status":"COMPLETED","sponsor":"Dr. Nazanin Alavi","startDate":"2020-04-29","conditions":"Generalized Anxiety Disorder","enrollment":115},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT06301061","phase":"NA","title":"Focal Microvibration and Chronic Lumbosacral Radicular Pain","status":"NOT_YET_RECRUITING","sponsor":"Federico II University","startDate":"2024-04-01","conditions":"Pain, Chronic, Lumbosacral Radiculopathy, Radicular; Neuropathic","enrollment":150},{"nctId":"NCT06252116","phase":"","title":"Study of Analgesic Action of Pregabalin, Duloxetine and Tramadol in Patients With Different Neuropathic Pain Phenotypes","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2018-03-05","conditions":"Neuropathic Pain","enrollment":100},{"nctId":"NCT06237595","phase":"NA","title":"Vagus Nerve Stimulation in Fibromyalgia","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2023-09-30","conditions":"Fibromyalgia","enrollment":90},{"nctId":"NCT06232473","phase":"PHASE4","title":"Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-01-01","conditions":"Functional Disorder","enrollment":424}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":81,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["duloxetine","Cymbalta"],"phase":"marketed","status":"active","brandName":"Duloxetine (Cymbalta)","genericName":"Duloxetine (Cymbalta)","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Duloxetine inhibits the reuptake of serotonin and norepinephrine in the central nervous system, increasing their availability at synaptic sites. Used for Major depressive disorder, Generalized anxiety disorder, Diabetic peripheral neuropathic pain.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}